DES - transgenderism and birth defects

Washington Post
The Washington Post reports that "DES was the biggest nostrum in quackery since snake oil . . . the medical community looked the other way. They didn't want to admit the mistake they made."

The DES debacle demonstrates the harm caused by the medical community when it fails to abide by the precautionary principle--"First, do no harm." Prescribing drugs without definitive evidence of their safety is irresponsible. The DES case should serve as a lesson: it's adverse effects are long-lasting, indeed they affect the health of women who took the drug during pregnancy, their daughters, and, it turns out, they affect the health of their sons and grandchildren.

The daughters of mothers who took DES "suffered malformed reproductive organs, which would later lead to increased infertility, tubal pregnancies and miscarriage, effectively robbing many of the chance to bear their own children." Furthermore, "Exposure to the drug also harmed male children, who face an increased risk for epididymal cysts -- non-cancerous growths on the testicles -- and varicose veins on the testicles."

Today, public officials--including the FDA and NIMH--and the medical community are similarly complicit in their failure to protect children and fetuses from the hazards posed by mind altering drugs. SSRI antidepressants are being prescribed recklessly to pregnant women and millions of previously healthy children.

The DES case demonstrates the tragic consequences of prescribing drugs whose benefits are not proven, but whose early adverse effects can be detected, and whose future long-lasting adverse effects on the developing brain and nervous system can be foreseen. FDA's failure to protect children and unborn fetuses is irresponsible.
READ ARTICLE

Center for Disease Control
Diethylstilbestrol (DES) is a drug once prescribed during pregnancy to prevent miscarriages or premature deliveries. In the U.S. an estimated 5 to 10 million persons were exposed to DES from 1938 to 1971, including pregnant women prescribed DES and their children. In 1971, the Food and Drug Administration (FDA) advised physicians to stop prescribing DES because it was linked to a rare vaginal cancer.

After more than 30 years of research, there are confirmed health risks associated with DES exposure. However, not all exposed individuals will experience DES-related health problems. Whether you know for sure or suspect you were exposed to DES, you can use CDC's DES Update to learn more about DES exposure and what you can do about it.

CDC - FOR MORE INFORMATION



What is DES?

Diethylstilbestrol (DES) is a synthetic estrogen that was developed to supplement a woman's natural estrogen production. First prescribed by physicians in 1938 for women who experienced miscarriages or premature deliveries, DES was originally considered effective and safe for both the pregnant woman and the developing baby.

In the United States, an estimated 5-10 million persons were exposed to DES during 1938-1971, including women who were prescribed DES while pregnant and the female and male children born of these pregnancies. In 1971, the Food and Drug Administration (FDA) issued a Drug Bulletin advising physicians to stop prescribing DES to pregnant women because it was linked to a rare vaginal cancer in female offspring.

More than 30 years of research have confirmed that health risks are associated with DES exposure. However, not all exposed persons will experience DES-related health problems. CDC's DES Update has more information about the health risks associated with DES exposure.
READ ARTICLE



Scientific Physical 
Proof Of Transsexualism
Transsexualism and sex changes through Chemistry Articles